NEVRO CORP. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1a230768-3498-4a84-b6ac-c2f3f157de14/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-113.4M | 2024-01-01 – 2024-12-31 | evidence 0001444380-25-000024 |
| FY 2023 | $-92.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-019464 |
| FY 2022 | $3.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-003296 |
| FY 2021 | $-131.4M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-006312 |
| FY 2020 | $-83.1M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-024174 |
| FY 2019 | $-103.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-021316 |
| FY 2018 | $-49.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-018079 |
| FY 2017 | $-36.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-011287 |
| FY 2016 | $-31.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-009430 |
| FY 2015 | $-67.4M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-583945 |
| FY 2014 | $-30.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-281205 |
| FY 2013 | $-26.0M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-097120 |
| FY 2012 | $-19.0M | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-097120 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).